-
LYNN HEALTH SCIENCE INSTITUTE IS LOOKING FOR PARTICIPANTS
PAID CLINICAL TRIAL
- Lasting up to 1 year
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:
-
Have a diagnosis of Gout
-
18 years of age or older
Gout is a form of arthritis that develops when uric acid crystals build up in the body. Uric acid is a waste product. When too much of it is in the bloodstream, it forms crystals over time. People with gout experience pain, redness, swelling, and warmth in the affected joints.
Learn More About the Location
Oklahoma City-East Side, OKPurpose Of Study
The purpose of this study is to Evaluate the Efficacy and Safety of Intravenous KRYSTEXXA® (pegloticase) Administered Every 4 Weeks Compared with KRYSTEXXA Administered Every 2 Weeks with Co-administration of Weekly Doses of Methotrexate in Participants with Uncontrolled Refractory Gout, Followed by an Open-label Extension, in Participants with Uncontrolled Refractory Gout (FORWARD II).
LEARN MORE ABOUT PARTICIPATING IN A CLINICAL TRIAL
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.
Find out More About Our Participation Program
Participation Information